These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 9421466)

  • 1. Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.
    Gilhar A; Ullmann Y; Berkutzki T; Assy B; Kalish RS
    J Clin Invest; 1998 Jan; 101(1):62-7. PubMed ID: 9421466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice.
    Gilhar A; Shalaginov R; Assy B; Serafimovich S; Kalish RS
    J Investig Dermatol Symp Proc; 1999 Dec; 4(3):207-10. PubMed ID: 10674367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice.
    Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
    J Invest Dermatol; 2001 Dec; 117(6):1357-62. PubMed ID: 11886495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice.
    Gilhar A; Landau M; Assy B; Shalaginov R; Serafimovich S; Kalish RS
    Arch Dermatol; 2002 Jul; 138(7):916-22. PubMed ID: 12071819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia areata: autoimmunity--the evidence is compelling.
    Kalish RS; Gilhar A
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):164-7. PubMed ID: 14582666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of alopecia areata in the human scalp graft/Prkdc(scid) (SCID) mouse system is characterized by a TH1 response.
    Gilhar A; Landau M; Assy B; Ullmann Y; Shalaginov R; Serafimovich S; Kalish RS
    Clin Immunol; 2003 Mar; 106(3):181-7. PubMed ID: 12706404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata.
    Sato-Kawamura M; Aiba S; Tagami H
    Arch Dermatol Res; 2003 Mar; 294(12):536-43. PubMed ID: 12624779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of infiltrating T cells in human scalp explants from alopecia areata to SCID nude mice: possible role of the disappearance of CD8+ T lymphocytes in the process of hair regrowth.
    Tsuboi H; Tanei R; Fujimura T; Ohta Y; Katsuoka K
    J Dermatol; 1999 Dec; 26(12):797-802. PubMed ID: 10659500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis resistance in peripheral blood lymphocytes of alopecia areata patients.
    Zöller M; McElwee KJ; Vitacolonna M; Hoffmann R
    J Autoimmun; 2004 Nov; 23(3):241-56. PubMed ID: 15501395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
    Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
    Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 interferon signature in the scalp lesions of alopecia areata.
    Ghoreishi M; Martinka M; Dutz JP
    Br J Dermatol; 2010 Jul; 163(1):57-62. PubMed ID: 20346028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
    Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
    Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
    Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
    Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
    Wasyłyszyn T; Kozłowski W; Zabielski SL
    Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
    McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
    Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymopentin in alopecia areata].
    Gruber DM; Sator MO; Kokoschka EM; Huber JC
    Acta Med Austriaca; 1998; 25(1):33-5. PubMed ID: 9576023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocytes, neuropeptides, and genes involved in alopecia areata.
    Gilhar A; Paus R; Kalish RS
    J Clin Invest; 2007 Aug; 117(8):2019-27. PubMed ID: 17671634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity: alopecia areata.
    Hordinsky M; Ericson M
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):73-8. PubMed ID: 14870990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.